Edition:
United States

Hemispherx Biopharma Inc (HEB)

HEB on American Stock Exchange

0.32USD
19 Oct 2017
Change (% chg)

$-0.01 (-4.50%)
Prev Close
$0.33
Open
$0.33
Day's High
$0.33
Day's Low
$0.32
Volume
168,829
Avg. Vol
314,174
52-wk High
$1.16
52-wk Low
$0.30

Select another date:

Fri, Sep 29 2017

BRIEF-Hemispherx Biopharma says files for resale of 5.4 mln shares of common stock, offered for sale by selling stockholders

* Hemispherx Biopharma - files for resale of of 5.4 million shares of common stock, offered for sale by selling stockholders - SEC Filing‍​ Source text: (http://bit.ly/2yegQEW) Further company coverage:

BRIEF-Hemispherx Biopharma Co's board has reviewed financial condition of company and anticipated needs of company to pursue its goals

* Co's board has reviewed financial condition of company and anticipated needs of company to pursue its goals

BRIEF-Hemispherx Biopharma announces corporate progress and financial results for the 6 months ended June 30 '17

* Hemispherx Biopharma announces corporate progress and financial results for the six months ended June 30, 2017

BRIEF-Hemispherx Biopharma updates on study of Ampligen

* Hemispherx human safety study of intranasal Ampligen with influenza vaccine shows Ampligen was generally well-tolerated ‍​

BRIEF-Hemispherx Biopharma updates status of immuno-oncology program in pancreatic cancer

* Hemispherx updates status of immuno-oncology program in pancreatic cancer

BRIEF-Hemispherx Biopharma announces quarterly loss per share $0.11

* Hemispherx Biopharma announces financial results for the three months ended March 31, 2017

Select another date: